top of page
Actorius logo web.webp

Proof of Precision.
Power of Innovation.

We are committed to utmost scientific rigour. Every product at Actorius Innovations and Research undergoes intense design and development. Our products are patented worldwide. We follow the most stringent quality norms (ISO13485) and applicable regulatory requirements for medical devices (rules 2017)

Actorius Patents
20 October 2025

Non-hemolytic compositions and methods of use for recovering disease-causing toxic constituents in the blood

A non-hemolytic adsorbent composition designed to isolate, quantify, and remove disease-causing toxic constituents from blood, supporting disease identification, monitoring, and therapeutic efficacy validation.

Read More
Actorius Patent
13 February 2023

Devices and methods for recovering disease-causing toxic constituents in the blood

A cost-effective, high-efficiency nanosystem for rapid circulating tumor cell enumeration.

Read More
Actorius Patents
22 April 2021

Multifunctional magneto-polymeric nanosystems for rapid targeting, isolation, detection and simultaneous imaging of circulating tumor cells

A multifunctional magneto-polymeric nanosystem for rapid targeting, isolation, detection, and imaging of circulating tumor cells to support cancer diagnostics and monitoring.

Read More
Actorius Patents
26 February 2020

Polymer based formulation for release of drugs and bioactives at specific GIT sites.

A polymer-based formulation designed for targeted release of drugs and bioactives at specific gastrointestinal sites, including the stomach, intestine, and colon.

Read More
  • Page 1
bottom of page